Savara Inc
NASDAQ:SVRA

Watchlist Manager
Savara Inc Logo
Savara Inc
NASDAQ:SVRA
Watchlist
Price: 3.2 USD -1.84% Market Closed
Market Cap: 552.4m USD

Operating Margin
Savara Inc

0%
Current
0%
Average
-5.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-103.2m
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Savara Inc
NASDAQ:SVRA
551.8m USD N/A
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
344.4B USD
29%
US
Amgen Inc
NASDAQ:AMGN
156.2B USD
22%
US
Gilead Sciences Inc
NASDAQ:GILD
132.7B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
130.9B USD
40%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
122.2B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
65.6B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.6B EUR
-1%

Savara Inc
Glance View

Market Cap
551.8m USD
Industry
Biotechnology

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The company is headquartered in Austin, Texas and currently employs 22 full-time employees. The company went IPO on 2001-06-25. The firm is focused on rare respiratory diseases. The Company’s lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of aPAP. Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the build-up of surfactant in the alveoli or air sacs of the lungs.

SVRA Intrinsic Value
2.4 USD
Overvaluation 25%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-103.2m
/
Revenue
0
What is the Operating Margin of Savara Inc?

Based on Savara Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top